Franchise Login | Webmail Login | LIS Login | Panel Report | Patient Report
+91 11 30611432 , 30611467
+91 11 30611432 , 30611467 
- Can Assist Test – Breast
- Cancer Testing by Liquid Biopsy
- HLA Typing
- ImuPro
- Cancer HOT SPOT Panel – 50 Genes by NGS
- Cell-free or Circulating Tumour DNA (ctDNA)
- Foundation one (solid tumors)
- PD – L1 TESTING
- BRCA 1 & 2
- Lung Cancer -ROS 1 Gene & Met Gene
- Panorama Test
- MammaPrint Test
- Myeloproliferative Leukemia (MPL) Mutation Analysis
- Calreticulin Mutation
Foundation one (solid tumors)
View / Download
- Comprehensive genomic profile that interrogates the entire coding sequence of 315 cancer-related genes plus select introns from 28 genes often rearranged or altered in solid tumor cancers.
- Identifies all classes of genomic alterations, including base pair substitutions, insertions and deletions, copy number alterations and select gene rearrangements.
- Identify clinically relevant genomic alterations associated with targeted therapies
- Quantify clinical markers associated with immunotherapy response
Foundation one Heme (hematology malignancies & sarcomas)
- Comprehensive genomic profile for hematologic cancers (leukemia, lymphoma and myeloma) and sarcomas.
- Designed to provide physicians with clinically actionable information relevant for diagnosis, risk-stratification and prognosis to guide treatment options for patients based on the genomic profile of their cancer.
- Assess routine cancer specimens for all genes that are currently known to be somatically altered in hematologic malignancies and sarcomas.
- Simultaneously detects all classes of genomic alterations, including base pair substitutions, insertions and deletions, copy number alterations and select gene rearrangements in 405 cancer-related genes.
- Also employs RNA sequencing across 265 genes to capture a broad range of gene fusions, a type of alteration that is a common driver of hematologic cancers and sarcomas.
